Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-6-13
pubmed:abstractText
Ebola virus causes a hemorrhagic fever syndrome that is associated with high mortality in humans. In the absence of effective therapies for Ebola virus infection, the development of a vaccine becomes an important strategy to contain outbreaks. Immunization with DNA and/or replication-defective adenoviral vectors (rAd) encoding the Ebola glycoprotein (GP) and nucleoprotein (NP) has been previously shown to confer specific protective immunity in nonhuman primates. GP can exert cytopathic effects on transfected cells in vitro, and multiple GP forms have been identified in nature, raising the question of which would be optimal for a human vaccine.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-10202932, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-10932225, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-10950971, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-11112476, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-11117750, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-11222689, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-11238859, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-12904795, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-14633608, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-15140961, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-15580728, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-15596847, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-15795265, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-15937495, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-16254351, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-8553543, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-8627650, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-8788172, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-8793545, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-8800795, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-9054520, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-9427604, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-9658086, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-9741429, http://linkedlifedata.com/resource/pubmed/commentcorrection/16683867-9820501
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1549-1676
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e177
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.
pubmed:affiliation
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Intramural